MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)
||
||

Cash Flow Overview

Change in Cash
-$510K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Maturities of available-for-sale...
    • Stock-based compensation
    • Accounts payable and accrued lia...
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Purchases of available-for-sale ...
    • Prepaid expenses and other curre...
    • Others
Cash Flow
2026-06-30
2026-03-31
2025-12-31
Net loss
-19,007
-32,948
-105,609
Non-cash consideration for acquired in-process research and development
-
-
67,659
Milestone liability change in fair value
175
-929
-
Change in fair value of sermonix pre-funded warrant
0
16,320
4,579
Stock-based compensation
3,181
662
6,102
Depreciation expense
227
231
972
Non-cash lease expense
75
74
273
Amortization of premiums and accretion of discounts on available-for-sale securities, net
228
260
329
Prepaid expenses and other current and long-term assets, net
2,218
396
-2,439
Accounts payable and accrued liabilities
1,138
-3,362
-21,342
Operating lease liability
-114
-112
-414
Other long-term liabilities
-187
-183
-59
Net cash used in operating activities
-16,958
-20,903
-45,729
Purchases of available-for-sale securities
10,225
20,615
37,643
Maturities of available-for-sale securities
26,559
5,075
21,749
Net cash (used in) provided by investing activities
16,334
-15,540
-15,894
Proceeds from exercise of common stock options and issuance of common stock under employee stock purchase plan
-
-
37
Proceeds from pipe financing
-
-
89,991
Issuance costs from pipe financing
-
-
7,567
Proceeds from issuance of common stock under employee stock purchase plan
114
-
-
Net cash provided by financing activities
114
-
82,461
Net increase (decrease) in cash, cash equivalents and restricted cash
-510
-36,443
20,838
Cash, cash equivalents and restricted cash, beginning of period
33,464
69,907
49,069
Cash, cash equivalents and restricted cash, end of period
32,954
33,464
69,907
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

LONA Cash Flow Sankey DiagramSankey diagram visualizing LONA cash flow for the periodMaturities ofavailable-for-sale securities$26,559K Proceeds from issuance ofcommon stock under...$114K Net cash (used in)provided by investing...$16,334K Net cash provided byfinancing activities$114K Canceled cashflow$10,225K Net increase(decrease) in cash, cash...-$510K Canceled cashflow$16,448K Stock-based compensation$3,181K Accounts payable andaccrued liabilities$1,138K Depreciation expense$227K Milestone liabilitychange in fair value$175K Non-cash lease expense$75K Purchases ofavailable-for-sale securities$10,225K Net cash used inoperating activities-$16,958K Canceled cashflow$4,796K Net loss-$19,007K Prepaid expenses andother current and...$2,218K Amortization of premiums andaccretion of discounts on...$228K Other long-termliabilities-$187K Operating lease liability-$114K

LeonaBio, Inc. (LONA)

LeonaBio, Inc. (LONA)